1 / 28

Pharmacy Compliance in the ASC

Pharmacy Compliance in the ASC. Christopher M. Dembny R.Ph . Nov 7, 2013. Compounding Pharmacies. Necessary? Evil? Necessary Evil?. Biography. Christopher M. Dembny R.Ph . Licensed pharmacist in Texas for 30 years Consultant pharmacist for surgery centers for 20 years

lamya
Download Presentation

Pharmacy Compliance in the ASC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacy Compliance in the ASC Christopher M. Dembny R.Ph. Nov 7, 2013

  2. Compounding Pharmacies Necessary? Evil? Necessary Evil?

  3. Biography • Christopher M. Dembny R.Ph. • Licensed pharmacist in Texas for 30 years • Consultant pharmacist for surgery centers for 20 years • Exclusively practicing in surgery centers and surgical hospitals for 13 years. • Currently consulting for > 70 ASC’s • ****Feel free to ask questions!

  4. Who has regulatory oversight? • 1. FDA • 2. DEA • 3. Texas DPS* • 4. State Board of Pharmacy * • 5. Texas DSHS • 6. JCAHO (if you pay them) • 7. AAAHC (if you pay them) • 8. CMS $$$ **

  5. What does the TSBP want to see? • 1. Annual controlled substance inventory • notarized • 2. CII invoices with DEA 222…or CSOS In separate file (signed by RPh and person receiving) • 3. Power of attorney to sign DEA 222 • 4 CIII-V invoices (separate) (signed) • 5. Controlled substance reproducible audit trail ****

  6. What does the TSBP want to see? • Controlled substance administration records • Date and time of administration • Patient name • Drug and dose administered • Signature of person administering *** • Waste (if any) and signature of person witnessing waste • Ordering practitioner • Must be maintained separately from chart

  7. What does the TSBP want to see? • 6. Library is adequate: • A. Pharmacy Rules • B. General Reference Text (Facts & Comp) • C. Drug Interaction text • D. Injectable Products • E. Antidotes and poison control # • F. Weight conversion chart

  8. What does the TSBP want to see? • 7. Controlled substance documentation • 8. Removal of stock log • 9. Policies and Procedures(see list in TPR 291.76) • 10. Licenses – Pharmacy, DPS, and DEA

  9. What does the TSBP want to see? • 11. “Adequate security” • 12. Transfers to other registrants • 13. Loss or theft reports – DEA 106 • Theft or significant loss • 14. Save for 2 years • 15. Pyxis – Omnicell??????

  10. What does the DPS want to see? Licenses Adequate security Reproducible audit trail Secure prescription pads Annual inventories

  11. What does DSHS/CMS look for?

  12. CMS – CFR 416.48 • § 416.48 Condition for coverage—Pharmaceutical • services. • The ASC must provide drugs and • biologicals in a safe and effective manner, • in accordance with accepted professional • practice, and under the direction • of an individual designated responsible • for pharmaceutical services. (TPR 291.76) • (a) Standard: Administration of drugs. • Drugs must be prepared and administered • according to established policies • and acceptable standards of practice.

  13. CMS – CFR 416.48 • (1) Adverse reactions must be reported • to the physician responsible for • the patient and must be documented in • the record. • (2) Blood and blood products must be • administered by only physicians or registered • nurses. • (3) Orders given orally for drugs and • biologicals must be followed by a written • order, signed by the prescribing • physician. • (b) [Reserved]

  14. DEA • They’ll tell you what they’re looking for. • I’ve never seen them visit when there wasn’t already a problem.

  15. Questions?????

  16. Compounding Pharmacies Necessary? Evil? Necessary Evil?

  17. How did we get here? • Drug shortages are worse than ever. • Cause (my opinion) • A. Online ordering • 1. everyone orders the cheapest product B. Lowers price and profit for manufacturer

  18. How did we get here? • C. Forces some manufacturers out of business • D. Others make EXACTLY what they think they will sell. With smaller profit margins, profit disappears if you make too much. • E. Now we have fewer manufacturers with less overstock.

  19. How did we get here? • F. Interruption of supply • 1. Natural disaster • 2. FDA shutdown • 3. Internal problem (strike – retooling) • If 1 of 10 manufacturers experiences an interruption, no problem • If 1 of 2 manufacturers experiences an interruption, BIG PROBLEM. SHORTAGES.

  20. Problem created • A. Shortages of necessary drugs 1. Fentanyl 2. Midazolam 3. Propofol • Shortages of Crash Cart Drugs 1. Mag Sulfate 2. Sodium Bicarbonate

  21. Are Compounding Pharmacies a viable answer? • Yes, but choose carefully. • Get approval from Med Exec. • The cheapest isn’t always the best. • The cheapest isn’t always the cheapest -- Ask those who used NECC.

  22. Picking a good compounder • A. Look for accreditation: • Pharmacy Compounding Accreditation Board (PCAB) • An independent accreditation organization • Appear to be the only one • Very stringent • Can’t ensure everything is perfect

  23. Picking a good compounder • B. Independent assessment • Consultant pharmacist can be a resource • International Association of Compounding Pharmacists (IACP) http://www.iacprx.org/ • http://www.iacprx.org/associations/13421/files/CPAQ%20REV%20with%20updated%20member%20number%20October%202012.pdf • This is the assessment tool from IACP

  24. Picking a good compounder • C. Consultant Pharmacist Assessment • D. I would use in-state compounders • FDA may prohibit shipping across state lines.

  25. Picking a good compounder • ************************************ • D. Ask for independent analysis • 1. Sterility a. bacterial b. fungal • 2. Quantitative Analysis

  26. Contact Information • Christopher M. Dembny R.Ph. • cdembny@tx.rr.com

More Related